HYMPAVZI sol inj 150 mg/ml stylo pré 1 ml
7680695560015
CH-69556
B02BX
06.01.1.
Reimbursement limitations:
BLUTPRODUKTE
Calcul des prix des préparations sanguines sur la base du prix « ex factory », …
1 / 3
google
Details
- Product number
- 6955601
- CPT
- -
- Packaging group
- 1
- Unit
- Stück
- Composition
- marstacimabum 150 mg, histidinum, histidini hydrochloridum monohydricum, saccharum, dinatrii edetas, polysorbatum 80, aqua ad iniectabile, ad solutionem pro 1 ml corresp. natrium 0.0062 mg.
Articles (1)
Hympavzi 150 mg, Injektionslösung im Fertigpen
Injektionslösung im Fertigpen
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
150.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.0062 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 6884.10
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/07/2025
Authorization holder
Pfizer AG
8052 Zürich
Authorization information
- Swissmedic authorization number
- 69556
- Drug name
- Hympavzi, Injektionslösung im Fertigpen
- Galenic form
- INLFP
- ATC Code
- B02BX
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 23/12/2024
- Authorization expiration date
- 22/12/2029
- IT number
- 06.01.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- HYMPAVZI sol inj 150 mg/ml stylo pré 1 ml
- Description (DE)
- HYMPAVZI Inj Lös 150 mg/ml Fertpen 1 ml
- Market launch
- 23/12/2024
- Narcotic (BTM)
- No